How to Value a Dental or Medical Practice With Industry-Specific Drivers
Why Practice Valuation Matters in Healthcare
A healthcare business valuation is never just a generic small-business exercise. In a dental or medical practice, the conclusion of value often affects a sale, partner buy-in or buyout, succession plan, litigation matter, estate and gift planning, financing request, purchase price allocation, physician compensation arrangement, or a regulatory fair market value review. The core valuation logic is familiar—an informed buyer pays for expected future economic benefit—but the facts that determine sustainable cash flow are unusually sensitive to provider productivity, billing rules, payer behavior, compliance risk, staffing, and intangible assets such as goodwill. The valuation profession’s own standards emphasize that no single formula fits all assignments, and healthcare-specific guidance stresses that specialized billing and coding rules, regulation, and intangible assets often drive a substantial share of value. (AICPA & CIMA, 2022; American Society of Appraisers [ASA], 2022; International Valuation Standards Council [IVSC], 2025).
That is why a healthcare business appraisal must start with purpose. If the engagement is for transaction planning, the analyst may need market value or fair market value. If it is for a strategic buyer’s internal decision, the relevant concept may be investment value, which can include synergies unavailable to ordinary market participants. IVS makes this distinction explicit: market value excludes buyer-specific “special value,” while investment value and synergistic value may include benefits unique to a particular acquirer. In practical terms, a hospital, private equity platform, or dental support organization may rationally pay more than standalone fair market value because it can centralize billing, improve purchasing power, or negotiate stronger payer rates after closing. That premium may be real, but it is not automatically the same thing as fair market value for every legal or tax purpose. (IVSC, 2025; IFRS Foundation, 2026).
The regulatory overlay makes the distinction even more important in medical practice transactions. CMS explains that the Stark framework now includes clarified definitions of “fair market value,” “general market value,” and “commercially reasonable,” while the HHS Office of Inspector General states that the Anti-Kickback Statute prohibits knowingly and willfully paying remuneration to induce or reward referrals for federally reimbursable business. For any practice with meaningful designated health services, ancillaries, management fees, lease arrangements, or physician compensation relationships, a valuation that quietly bakes referral value into compensation can create more than a pricing problem; it can create a compliance problem. (Centers for Medicare & Medicaid Services [CMS], 2026a; U.S. Department of Health and Human Services, Office of Inspector General [HHS OIG], n.d.).
The bottom line is simple: a dental or medical practice is worth the present value of the earnings that are actually transferable to a buyer, adjusted for risk, growth, and asset support. That sounds straightforward, but healthcare forces the valuator to answer several hard questions that do not arise with the same intensity in many other industries: How much of current profit belongs to the owner’s labor rather than the enterprise? How durable is the patient base if the lead doctor exits? Are reimbursement rates keeping up with inflation? Will staffing shortages cap growth? Is the observed transaction data arm’s length, or does it reflect platform synergies, distressed terms, or unusual legal structures? Standards from the IRS, IVSC, and ASA all point in the same direction: analyze the facts, use more than one lens where appropriate, and avoid formulaic shortcuts. (Internal Revenue Service [IRS], 2014; ASA, 2022; IVSC, 2025).
Industry-Specific Drivers of Value
The drivers that matter most in healthcare are not mysterious, but they are highly practice-specific. In both dental and medical practices, value rises when earnings are repeatable, compliance is clean, growth is realistic, and patient demand is not excessively dependent on a single individual. Value falls when cash flow is fragile, concentrated, poorly documented, undercapitalized, or inflated by owner-specific economics that will not transfer to the next owner. The IRS framework associated with Revenue Ruling 59-60 still provides a useful backbone here: analyze the history of the enterprise, the economic outlook and industry outlook, financial condition, earning capacity, dividend-paying capacity, goodwill and other intangible value, market evidence, and other relevant factors. In healthcare, those same factors translate into provider concentration, payer mix, staffing capacity, referral durability, lease economics, and the quality of normalized earnings. (IRS, 2014; IVSC, 2025).
The value-driver matrix
| Driver | Why it matters | Dental emphasis | Medical emphasis |
|---|---|---|---|
| Normalized provider compensation | Separates labor income from enterprise earnings | Owner-dentist often mixes clinical pay, profit, and perks | Shareholder physicians often mix compensation, productivity bonuses, and ownership return |
| Personal vs. enterprise goodwill | Tests whether value transfers after the seller leaves | Chairside relationships, recall base, hygiene continuity, reputation | Physician brand, referral pull, patient panel loyalty, specialty-specific reputation |
| Payer mix and rate quality | Determines gross margin durability and reimbursement risk | Private pay, commercial dental insurance, Medicaid mix, network participation | Medicare, Medicaid, commercial, Medicare Advantage, value-based contracts |
| Capacity and demand | Determines near-term growth without major capex | Active patient base, hygiene utilization, operatories, case acceptance | Panel size, work RVUs, exam room utilization, visit mix, ancillary throughput |
| Workforce stability | Caps growth and affects margin | Hygienist and assistant recruitment, front-office retention | Physician retention, APP staffing, coder/biller quality, nurse and MA turnover |
| Asset support and capex | Tests how much new investment a buyer must make | Imaging, chairs, sterilization, software, leaseholds | EHR, diagnostic equipment, furniture/fixtures, procedure-room equipment |
| Regulatory and billing quality | Protects cash flow and reduces discount-rate risk | HIPAA, coding, documentation, insurance claims discipline | Stark, AKS, HIPAA, coding, modifier use, incident-to and supervision rules |
| Buyer universe and structure | Influences observed market evidence | Solo buyers, group practices, DSOs | Physician groups, hospitals, MSOs, PE-backed platforms |
This matrix is a synthesis of the dominant issues that recur in professional standards and current dental and physician practice research. It captures why a practice with similar revenue can command a very different value if one practice has stable staffing, diversified patients, and transferable systems, while the other depends on a founder with weak documentation and a short lease. (AICPA & CIMA, 2022; IRS, 2014; ASA, 2022; IVSC, 2025).
Normalized earnings are more important than reported profit
In a professional practice, reported net income or even reported EBITDA usually cannot be taken at face value. Owner-operators often pay themselves in a mix of salary, distributions, rent from related entities, automobile expenses, family payroll, personal travel, and discretionary spending. In a dental office, a founder may also be the lead producer, which means some of the “profit” is really compensation for clinical work. In a medical group, a shareholder physician may be underpaid or overpaid relative to fair market compensation for work relative value units, call burden, management duties, or specialty norms. ASA’s standards require financial statement analysis and, where appropriate, adjustments to reported financial information; those adjustments are made solely to assist in reaching a conclusion of value and must be described and supported. (ASA, 2022).
That point is central to healthcare valuation. A buyer is purchasing the economics of the enterprise, not the illusion created by an owner’s tax planning. The recurring question is not “What was EBITDA?” but “What are the maintainable earnings of the practice after paying fair compensation for the labor needed to produce those earnings?” For small owner-operated offices, that can mean replacing a simplistic EBITDA multiple with an analysis of adjusted earnings after a market-rate dentist or physician compensation charge. For larger groups, it may mean the opposite—rebuilding economics from physician-level production, normalized collections, support staffing, and overhead allocation instead of relying on raw book income. (ASA, 2022; IVSC, 2025).
Goodwill matters, but transferability matters more
For many healthcare practices, the largest asset is not the equipment. It is goodwill: the expectation that patients will continue to come back and that the business can continue operating as a going concern. The IRS training aid summarizing the traditional valuation factors notes that goodwill and other intangible value are fundamental considerations and also states that goodwill is ultimately tied to earning capacity. AICPA’s healthcare valuation guidance similarly emphasizes that intangible assets can constitute the majority of a healthcare practice’s value. (IRS, 2014; AICPA & CIMA, 2022).
But healthcare goodwill is not monolithic. A valuation must distinguish enterprise goodwill from personal goodwill. Enterprise goodwill arises from systems, location, trained staff, payer contracts, brand, patient records, established recall processes, and multi-provider continuity. Personal goodwill arises when patients or referral sources are attached to a particular dentist or physician rather than to the practice itself. The more a practice behaves like a “one-doctor” business with weak succession planning, the more a buyer will discount value or reclassify part of the observed economics away from transferable enterprise cash flow. The IRS materials are direct on this point: the loss of the manager of a “one-man” business can depress value if trained successors are lacking. (IRS, 2014).
For dental practices, the practical question is whether the patient base is loyal to the office or only to the founder. A strong hygiene department, stable associates, consistent recall, and high treatment acceptance support enterprise goodwill. A practice where a retiring owner still performs nearly all production and has weak handoff planning typically suffers a sharper goodwill haircut. For medical practices, the same principle shows up in patient panel stickiness, specialty referral dependence, provider credentialing continuity, and whether ancillary volume belongs to the system or the individual physician. (IRS, 2014; AICPA & CIMA, 2022).
Payer mix is not just a revenue metric; it is a risk metric
Payer mix may be the single most underappreciated driver of practice value. Two practices with the same top-line revenue can have radically different cash flow quality depending on commercial rates, Medicare exposure, Medicaid exposure, contractual adjustments, denial trends, collection discipline, and out-of-network strategy. Healthcare valuation is not only about volume; it is about monetization quality. (CMS, 2026b; MedPAC, 2026).
The current dental evidence is especially striking. The ADA Health Policy Institute reported that for dentists looking ahead to 2026, the top reported challenges were low insurance reimbursement, denials, and related insurance issues at 55.3%, staffing and recruitment at 54.2%, and increasing expenses and overhead at 41.5%. The same body of research has also shown that provider reimbursement in dentistry has not kept pace with inflation or with practice expenses, creating what the ADA describes as a significant fiscal squeeze on practices. In the Q4 2025 survey, 29.3% of owner dentists reported dropping out of some dental insurance networks during 2025, and among those who dropped networks, the average share of the patient base in those networks was 24.9%. Those figures matter enormously for value because network exits can improve margin, hurt patient retention, or both, depending on local demographics and substitute capacity. (American Dental Association Health Policy Institute [ADA HPI], 2025; ADA HPI, 2026a).
Medical practices face the same issue through a different payment architecture. Medicare physician payment is built on the physician fee schedule, which CMS and MedPAC describe as a formula based on relative value units, geographic adjustments, and a conversion factor. MedPAC reported that in 2024 the ratio of private insurance payment rates to fee-for-service Medicare payment rates rose to 147% and that physician compensation reached a median of $369,000. Medicare policy changes therefore affect value directly through the floor rate for many services and indirectly through commercial contracting leverage. If a medical practice’s historical margin depends on unusually favorable commercial rates, buyer diligence will test whether those rates are durable under ownership change and whether they are location-specific, provider-specific, or system-dependent. (CMS, 2026b; MedPAC, 2025, 2026).
Capacity, access, and patient demand
Valuation is future-looking, so today’s capacity utilization matters as much as yesterday’s earnings. If a practice is full, has stable demand, and can raise output without large capital needs, value rises. If it is simultaneously overworked and unable to recruit, a buyer may still see value—but with operational risk. If it is underutilized and demand is soft, the valuation must avoid paying for purely theoretical volume. (IVSC, 2025; IRS, 2014).
In dentistry, demand signals are mixed rather than universally strong. ADA HPI reported that consumer dental spending was up 3% in 2025 through September on an inflation-adjusted basis, but it also reported that in Q4 2025 one-third of dentists said they were not busy enough, only 12% said they were too busy to treat all patients requesting care, and 18% said they treated all patients but were overworked. At the same time, appointment wait times for new patients averaged 13.4 days in Q4 2025, roughly similar to the prior year. These data show why dental valuation needs local operating metrics rather than national assumptions: a mature suburban general practice with hygiene bottlenecks may deserve a higher growth forecast than a similar-sized office with weak patient flow and open chair time. (ADA HPI, 2026a).
For physician practices, demand is often mediated by local consolidation, care setting, and insurer relationships. The AMA reports that the share of physicians working in private practices fell from 60.1% in 2012 to 42.2% in 2024, reflecting a continued move toward larger and nonphysician-owned structures. That structural change matters for the market approach because a small independent practice may not have the same bargaining position, technology budget, or overhead profile as the hospital-owned or private-equity-backed comparables a broker cites. (American Medical Association [AMA], 2026a).
Workforce constraints and operating leverage
No current healthcare valuation can ignore labor. In dentistry, ADA HPI reported that prices for dental equipment and supplies were up 5% from the beginning of 2025, while longer-term hourly earnings of dental office staff had risen slightly faster than overall inflation. It also reported that 31.4% of dentists recruited hygienists and 34.9% recruited assistants in Q4 2025, with dental hygienists identified as the hardest position to recruit. These facts directly affect value because under-staffed hygiene chairs suppress production, force doctors into lower-value tasks, and raise execution risk for a buyer’s forecast. (ADA HPI, 2026a).
Medical practices face a related but broader issue. MedPAC reported that physician compensation grew 6% in 2024, while nonphysician practitioner compensation also rose, and the AMA notes that burdensome regulation, payment pressure, and costly resources remain important reasons practices sell. A valuation that simply annualizes last year’s margin without considering labor inflation, recruitment difficulty, and administrative burden is usually overstating maintainable earnings. (MedPAC, 2026; AMA, 2026a).
Market structure affects observed pricing
Market structure does not directly set value, but it affects comparable transaction evidence and post-close economics. In dentistry, peer-reviewed research found that higher commercial dental insurance concentration was associated with dentists being less likely to own a practice and that dentists appear to consolidate in response to increasing concentration among commercial dental insurers. In medicine, a recent JAMA Health Forum study found that in 2022 nearly half of primary care physicians were hospital-affiliated and that negotiated office-visit prices were 11% higher for hospital-affiliated and 8% higher for private-equity-affiliated primary care physicians than for independent physicians. GAO’s 2025 consolidation review separately reported that physician consolidation can increase spending and prices, while effects on quality and access are less clear. For valuation, the implication is practical: observed multiples and transaction prices may embed bargaining power or synergies that an ordinary standalone buyer cannot reproduce. (Nasseh et al., 2020; Singh et al., 2025; U.S. Government Accountability Office [GAO], 2025).
Choosing and Applying Valuation Methods
Professional standards converge on three principal valuation methods or, more precisely, valuation approaches: the income approach, the market approach, and the asset approach. In practice, the strongest healthcare valuations use more than one approach unless facts clearly support a single method. ASA’s standards explicitly address financial statement adjustments, the asset approach, the income approach, and the market approach for business valuation, while IVS 103 frames the same three approaches as the core toolkit. (ASA, 2022; IVSC, 2025).
The income approach is usually the anchor for going-concern practices
For an established dental or medical practice that will continue operating, the income approach is often the most conceptually powerful method because it asks the right question: what are the present values of future cash flows available to the enterprise or equity holders? IVS states that the income approach is especially relevant when future income amounts and timing can be reasonably projected and that investors expect a return commensurate with risk. (IVSC, 2025).
Within the income approach, the two most common methods are capitalization of earnings and discounted cash flow (DCF). Capitalization of earnings works best when future performance is expected to resemble a normalized steady state. That often fits mature, stable dental practices with predictable recall systems or established physician groups with steady provider rosters and no major near-term disruptions. The DCF method is better when the practice is changing in ways that matter—adding associates, losing a founder, dropping insurance networks, opening a new site, making large capex investments, restructuring staffing, or integrating acquisitions. IVS describes DCF as discounting forecast cash flows back to the valuation date and lays out the key steps: select the right cash flow definition, choose the explicit forecast period, build the forecast, determine terminal value, set the discount rate, and discount the cash flows and terminal value to present value. (IVSC, 2025).
That is where healthcare-specific judgment becomes essential. For a professional practice, raw EBITDA is often a poor proxy for distributable cash flow. The valuator usually starts by normalizing provider compensation, then builds cash flow after realistic maintenance capex, working capital needs, and taxes. In a dental office, that may mean charging the practice for the market cost of a replacement owner-dentist and separately evaluating hygiene capacity. In a medical group, it may mean reconciling work RVUs, support staff ratios, billing efficiency, and site-of-service dynamics before concluding that current earnings are sustainable. (ASA, 2022; IVSC, 2025).
DCF is strongest when future change is the story
The phrase discounted cash flow is common in investment banking, but in healthcare it becomes most useful when a practice’s economics are in transition rather than in equilibrium. A founder retirement, a shift from fee-for-service toward more value-based contracts, withdrawal from low-rate insurance networks, a new multi-specialty referral strategy, or a staffing normalization plan can all make trailing earnings misleading. DCF allows the analyst to model those transitions explicitly rather than burying them in a crude multiple. (IVSC, 2025; AMA, 2026a; ADA HPI, 2025).
IVS also provides useful discipline around discount rates. It notes that common methods for developing or corroborating discount rates include the capital asset pricing model (CAPM), weighted average cost of capital (WACC), observed or inferred yields, and the build-up method. The key requirement is consistency: post-tax cash flows should be matched with a post-tax discount rate, real cash flows with a real rate, and cash flows to the whole enterprise with WACC rather than an equity-only return. In healthcare, risk premiums should usually reflect provider concentration, payer concentration, compliance quality, reimbursement trajectory, staffing risk, local competition, and capital intensity—not vague market narratives. (IVSC, 2025).
Terminal value deserves special caution. IVS notes that common terminal value methods include the Gordon growth model, a market-based exit value, and salvage value or disposal cost for finite-lived assets. For professional practices, the common danger is using a terminal growth or exit multiple that quietly assumes perpetual “peak” economics. A dental office that is already founder-dependent, short on hygienists, and facing reimbursement pressure should not be valued as if today’s best margin will continue forever. Likewise, a medical practice enjoying unusually favorable payer rates because it is expected to be rolled into a larger platform may warrant a lower fair-market-value terminal assumption than a strategic buyer’s investment case would show. (IVSC, 2025).
The market approach is indispensable, but it is easy to misuse
The market approach estimates value by comparing the subject practice with comparable public companies, comparable transactions, or prior transactions involving the subject itself. IVS states that the approach should use price information from identical or comparable assets and that the best evidence often comes from recent arm’s-length transactions in the same industry and economic context. For business valuation specifically, IVS identifies three common market data sources: public markets, acquisition markets, and prior transactions or offers involving the subject business. (IVSC, 2025).
In theory, that sounds straightforward. In practice, it is one of the hardest parts of healthcare valuation, because “comparability” is often weak. A two-doctor pediatric office is not truly comparable to a PE-backed multi-site dermatology platform. A solo general dentist in a suburban leasehold is not directly comparable to a DSO tuck-in acquisition where buyer synergies include centralized procurement, multi-site marketing, shared management, and lower financing costs. IVS specifically warns that reliability is reduced when transaction information is hearsay, incomplete, distressed, not arm’s length, or reflects a synergistic purchaser. That warning should be front of mind in dental and medical practice valuation, where transaction databases are often proprietary, small-deal disclosures are sparse, and platform economics can distort pricing. (IVSC, 2025; GAO, 2025).
That is also why practitioners should be careful with rules of thumb. Simple percentages of collections, chair count, or revenue may survive in brokerage conversations, but they are not authoritative valuation methods. The IRS materials emphasize that no formula can be devised for the multitude of valuation issues and that all relevant facts must be considered. For a professional practice, a revenue multiple can be a useful market sanity check, but it is a weak primary method unless profitability, doctor compensation, payer structure, age of equipment, and growth risk are also normalized. (IRS, 2014; ASA, 2022).
EBITDA is useful, but only after adjustment
Because the user requested SEO coverage of EBITDA, it is worth being explicit: EBITDA is useful in healthcare valuation, but only after careful adjustment. EBITDA can provide a clean bridge between a practice and market transaction data, especially for larger clinics and multi-provider groups, because buyers often think in enterprise-value-to-EBITDA terms. But in owner-operated practices, EBITDA is only meaningful after recasting owner pay, discretionary spending, related-party rent, unusual legal costs, nonrecurring bonuses, start-up expenses, and underinvestment in maintenance. Unadjusted EBITDA is often worse than useless because it creates a false appearance of comparability. (ASA, 2022; IVSC, 2025).
The asset approach is critical in the right cases
The asset approach values the enterprise based on the fair value of its assets minus liabilities. ASA defines it as a general way of determining value using methods based on the value of assets net of liabilities and notes that it may be analogous to the cost approach in other appraisal disciplines. Crucially, ASA also states that the asset approach should not be the sole approach used for operating companies appraised as going concerns unless that approach is customary among buyers and sellers or otherwise well supported. (ASA, 2022).
That principle fits healthcare well. The asset approach is usually not the lead method for a healthy, profitable dental or medical practice because buyers pay for going-concern earnings, patient continuity, staff systems, and goodwill—not just chairs, computers, and x-ray units. But it becomes very important in several settings: start-ups and de novo sites with weak operating history; distressed practices with declining goodwill; asset-heavy specialty clinics where equipment is substantial; and any assignment where a liquidation or break-up premise is relevant. It is also essential as a floor or cross-check, especially when market and income indications diverge sharply. (ASA, 2022; IVSC, 2025).
A practical method-selection table
| Situation | Income approach | Market approach | Asset approach |
|---|---|---|---|
| Stable mature general dental practice | Usually primary | Strong cross-check | Secondary floor |
| Multi-provider medical group with steady earnings | Usually primary | Strong if reliable comps exist | Secondary |
| Founder retirement within 12–24 months | Strong, especially DCF | Useful but needs provider-risk adjustments | Secondary |
| Start-up or de novo clinic | Useful only with credible forecast | Often weak due few true comps | Often important |
| Distressed declining practice | Useful if turnaround is credible | Often sparse and noisy | Often primary or heavily weighted |
| Platform or tuck-in acquisition analysis | Useful for FMV and investment value | Useful but must separate synergy pricing | Secondary |
This table is a practical synthesis of ASA and IVS standards applied to common healthcare practice scenarios; the appropriate weighting always depends on facts, data quality, and the standard of value. (ASA, 2022; IVSC, 2025).
Step-by-Step Valuation Workflow
The most reliable dental and medical practice valuations follow a disciplined sequence. The exact order can vary by analyst, but skipping steps usually leads to inflated multiples, misunderstood risk, or double-counting of goodwill.
Define the assignment correctly
The first step is to define the standard of value, premise of value, subject interest, valuation date, and intended use. Is the analyst valuing 100% of the enterprise, a minority interest, or a partner unit? Is the premise a going concern, an orderly disposition, or liquidation? Is the purpose transaction planning, tax, litigation, financial reporting, compensation, or financing? IVS, ASA, and accounting fair-value frameworks all stress that the basis of value drives the relevant assumptions and the treatment of entity-specific benefits. (IVSC, 2025; IFRS Foundation, 2026; ASA, 2022).
Gather the operating record, not just the tax return
Three to five years of income statements, balance sheets, tax returns, production reports, and payroll records are a starting point, not the finish line. For a dental practice, the analyst should also gather active-patient counts, new-patient trends, hygiene visit volume, provider-level production, collection percentages, case acceptance, insurance participation, operatories, and equipment lists. For a medical practice, the file should include provider rosters, work RVUs or production statistics, payer mix, denial trends, ancillary service lines, site-of-service exposure, physician compensation formulas, and lease or real estate details. IRS guidance notes that comparative statements, recent balance sheets, and supporting schedules are essential because they reveal liquidity, working capital, fixed assets, indebtedness, capital structure, and non-operating assets. (IRS, 2014; AMA, 2026a; ADA HPI, 2025).
Normalize earnings
This is the stage where the valuation either becomes credible or collapses. The appraiser adjusts historical results for discretionary owner expenses, nonrecurring legal or consulting costs, unusual bonuses, one-time repairs, pandemic distortions if still relevant, non-operating assets, related-party rent, and most importantly owner compensation. ASA’s BVS-II requires that financial statement adjustments be analyzed, described, and supported. (ASA, 2022).
A simple normalization bridge often looks like this:
Reported EBITDA
+ Personal / discretionary expenses
+ Nonrecurring legal / consulting / repair items
+ Under-market owner salary add-back (if applicable)
- Market replacement compensation for clinical and administrative labor
- Market rent adjustment (if related-party lease is above or below market)
- Maintenance capex normalization, if historical EBITDA overstates cash generation
= Adjusted EBITDA / maintainable operating earnings
That bridge is conceptually straightforward, but the replacement compensation line is where many healthcare valuations go wrong. A founder’s clinical labor is not goodwill; it is labor. If the owner is producing dentistry or medicine that a replacement provider must perform, the valuation cannot capitalize those economics without charging for them. The same approach applies to an underpaid spouse on the payroll, above-market rent to a related real estate entity, or excess owner perks. (ASA, 2022; IVSC, 2025).
Analyze operational KPIs before forecasting
A practice forecast should emerge from operations, not from hope. For dental offices, forecast quality improves materially when it is built from hygiene reappointment rates, new-patient flow, doctor day availability, assistant coverage, procedure mix, fee schedule strategy, and chair utilization rather than a blunt percent-growth assumption. For medical practices, stronger forecasts come from provider productivity, payer-coding mix, encounter counts, ancillary conversion, panel growth, staffing ratios, and reimbursement assumptions linked to actual contracts or CMS policy. Current industry data show why this matters: dental reimbursement and practice costs are diverging, staffing remains difficult, and physicians continue facing payment pressure and consolidation incentives. (ADA HPI, 2025; ADA HPI, 2026a; MedPAC, 2026; AMA, 2026a).
Select the right income method
If the practice is relatively steady and mature, capitalization of earnings may be efficient. If the practice is changing materially, DCF is usually better. IVS states that the income approach is appropriate where future income can be reasonably projected, but it also warns that uncertainty around timing and amount of cash flows should be reflected in the analysis. In healthcare, that usually means distinguishing between risk that belongs in the cash flow and risk that belongs in the discount rate, rather than hiding everything in a high cap multiple. (IVSC, 2025).
Build the discount or capitalization rate
A discount rate should be reasoned, not ritualistic. IVS identifies CAPM, WACC, inferred yields, and build-up methods as common tools. In a small healthcare practice, analysts often use a build-up style framework with risk components for size, company-specific risk, provider concentration, reimbursement instability, local competition, staffing difficulty, technology needs, and compliance exposure. In larger groups with meaningful debt capacity and cleaner benchmarking, a WACC framework may be more natural. What matters is consistency and documentation. (IVSC, 2025).
Apply the market approach as a check, not a shortcut
Comparable transactions and market multiples are important, but they should be used as evidence rather than as magic. The analyst should adjust for specialty, geography, size, provider dependence, growth, payer quality, equipment age, legal structure, and whether observed deals involved strategic buyers with synergies. IVS stresses that a market approach requires a reasonable basis for comparison and that unreliable or synergy-laden transactions require caution. That warning is especially relevant now that physician and dental practice transactions increasingly occur within consolidated buyer ecosystems. (IVSC, 2025; Singh et al., 2025; Nasseh et al., 2020; GAO, 2025).
Add the asset support and reconcile the indications
Even when the income approach drives value, the analyst still needs to understand asset support. How much normalized working capital should transfer? Are there non-operating cash balances? Is there deferred capex hidden in old equipment? Are leasehold improvements likely to be stranded at expiration? Is there excess or obsolete inventory? The final conclusion typically reconciles the approaches rather than averaging them mechanically. A stable, profitable going concern may receive heavier weight on income and market indications; a distressed office may receive heavier weight on asset value. (ASA, 2022; IVSC, 2025).
Worked Examples and Case Studies
The examples below are hypothetical and designed to show how the valuation logic works in practice. They are not implied market quotations.
Case study: general dental practice with transferable goodwill
Assume a six-operatory general dental practice with $1.85 million in collections, one owner-dentist, one associate two days per week, a strong hygiene base, and stable staff. Historical books show reported EBITDA of $340,000, but the owner pays herself only $250,000 for a full-time clinical and managerial role. Buyer diligence concludes that fair replacement compensation for that role is $380,000. The books also include $35,000 of personal and nonrecurring items, while related-party rent is $20,000 below market.
| Item | Amount |
|---|---|
| Reported EBITDA | $340,000 |
| Add back personal/nonrecurring items | $35,000 |
| Less under-market owner compensation adjustment | $(130,000) |
| Less rent normalization | $(20,000) |
| Adjusted EBITDA / maintainable earnings | $225,000 |
The valuation story here is not “collections times a rule of thumb.” It is “maintainable earnings supported by operations.” If the practice has a stable recall system, strong hygiene utilization, diversified production, good online reputation, updated imaging, and a lease that extends beyond the transition period, a buyer may reasonably pay for meaningful goodwill. If comparable non-synergistic market evidence suggests a multiple around 4.5x to 5.0x adjusted EBITDA, the indicated enterprise value would fall in the general range of roughly $1.0 million to $1.1 million before adding unusual excess cash or subtracting debt. But if the same practice were founder-dependent, short on hygienists, and facing imminent lease risk, the same revenue could support a materially lower indication. The logic follows professional standards: normalize the earnings, assess risk, and cross-check with market evidence rather than relying on gross revenue alone. (ASA, 2022; IVSC, 2025; IRS, 2014).
What would push value higher? A multi-year associate retention plan, stronger hygiene scheduling, documented active patient counts, lower insurance dependence, modern equipment, and a demonstrated ability to convert case presentation into treatment. What would push value lower? Heavy concentration in a few insurance plans, weak recare follow-through, large near-term capex, and evidence that most patients are loyal only to the retiring founder. Current ADA evidence supports the importance of precisely those variables because practices are facing reimbursement pressure, labor pressure, and uneven demand across local markets. (ADA HPI, 2025; ADA HPI, 2026a).
Case study: four-physician primary care group with strategic-buyer noise
Assume a four-physician primary care group with two nurse practitioners, one clinic location, and $5.6 million of revenue. Reported EBITDA is $780,000 after shareholder compensation. Diligence identifies $60,000 of excess family payroll, $90,000 of one-time transaction and legal costs, a $50,000 above-market rent issue, and one physician who is undercompensated by $150,000 relative to replacement market labor.
| Item | Amount |
|---|---|
| Reported EBITDA | $780,000 |
| Add back excess family payroll | $60,000 |
| Add back one-time legal/transaction costs | $90,000 |
| Less under-market physician compensation | $(150,000) |
| Less above-market rent adjustment | $(50,000) |
| Adjusted EBITDA / maintainable earnings | $730,000 |
Suppose a market data service shows recent platform and tuck-in medical practice transactions around 6.0x to 7.0x EBITDA. A careless analyst might stop there and claim value near $4.4 million to $5.1 million. A better analyst asks what kind of deals those were. If the observed buyers were hospital systems or PE-backed consolidators, part of those prices may reflect synergies, stronger contracting leverage, a lower cost of capital, or post-close billing opportunities not available to an ordinary buyer. IVS is clear that market value excludes special value to a particular buyer, and recent public research shows that hospital and PE affiliation can improve commercial pricing relative to independent practices. That is precisely the kind of context that can distort a naïve multiple-based market approach. (IVSC, 2025; Singh et al., 2025; GAO, 2025).
A fair-market-value analysis might therefore weight DCF or normalized earnings more heavily, especially if the group’s payer rates are average and there is no evidence the same pricing gains are transferable to an ordinary physician buyer. If a DCF built on maintainable volume, realistic Medicare and commercial reimbursement assumptions, 2%–3% long-term nominal growth, physician retention risk, and moderate capex produces an enterprise value around $3.8 million to $4.1 million, that result may be more defensible than a synergy-inflated market multiple. The exercise also highlights a practical truth: in medical practice valuation, the highest headline offer and fair market value are often not the same number. (IVSC, 2025; CMS, 2026a; HHS OIG, n.d.; MedPAC, 2026).
Case study: distressed specialty practice where the asset approach matters more
Now assume a small specialty practice that lost its lead physician, has falling collections, outdated equipment, a short nonassignable lease, and weak staffing. Historical earnings are negative, and referral volume has not stabilized since the founder exit. In that scenario, a buyer may not pay much for historical goodwill because transferability has already been disproven. The income approach may still be used, but if projected cash flow is speculative, the asset approach becomes more important. ASA’s standards explicitly support heavier use of the asset approach where the business is not being appraised as a healthy going concern. (ASA, 2022; IRS, 2014).
The lesson from this third case is important for both sellers and buyers: a practice is not valuable merely because it once was valuable. A current business appraisal must measure what is still economic and still transferable on the valuation date. In healthcare, that means asking whether the systems, staff, patient relationships, and legal rights that once supported goodwill actually remain intact. (IVSC, 2025; IRS, 2014).
Regulatory, Accounting, Tax, and Transaction Considerations
Fair market value, commercial reasonableness, and referral risk
Healthcare valuation is unusual because value cannot be divorced from legal structure. CMS states that the Stark regulatory framework now includes defined concepts of fair market value, general market value, and commercial reasonableness. HHS OIG separately explains that the Anti-Kickback Statute prohibits remuneration intended to induce or reward referrals for federally reimbursable services and that excessive compensation for arrangements such as medical directorships can be problematic. For a medical practice transaction, therefore, the analyst cannot simply “bake in” future referral-driven economics from a hospital or ancillary relationship and call the result fair market value. The valuation must identify what a market participant would pay for the practice itself under the chosen standard of value, not what a specific buyer might justify because of protected or regulated referral streams. (CMS, 2026a; HHS OIG, n.d.).
This issue also affects post-close compensation and management structures. Suppose a physician group sells to an MSO-supported structure and the buyer proposes high post-close management fees, above-market rent, or compensation terms that appear disconnected from actual work performed. That may be more than an integration issue. The valuation often becomes the evidentiary bridge showing whether economics are supported by fair market labor, fair market rent, or fair market management services rather than by referral expectations. (CMS, 2026a; HHS OIG, n.d.).
HIPAA due diligence and record transfer
Due diligence in healthcare is also different because patient information is part of the operating system. HHS explains that the HIPAA Privacy Rule permits covered entities to use and disclose protected health information for treatment, payment, and healthcare operations, and it explicitly includes “sale or transfer of assets” within healthcare operations. HHS also notes that disclosures for payment and healthcare operations must be limited to the minimum necessary. That means patient records and data systems can be addressed in diligence and transfer planning, but the process needs disciplined privacy controls, role-based access, and appropriate transaction documentation. (U.S. Department of Health and Human Services, Office for Civil Rights [HHS OCR], 2013, 2025).
From a valuation perspective, that matters because charts, records, and data are not simply a line item called “intangibles.” Their usefulness depends on lawful transfer, continuity of treatment and operations, patient notification requirements where applicable, and the buyer’s ability to preserve continuity without creating privacy risk. In other words, the value of the record base is partly legal and operational, not merely statistical. (HHS OCR, 2013, 2025).
Financial reporting and fair value measurement
If the valuation is being prepared for financial reporting—such as purchase price allocation, impairment testing, or a fair-value disclosure—then the relevant accounting framework matters. IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, emphasizing that fair value is market-based rather than entity-specific. FASB’s Topic 820 update uses the same basic “exit price” logic for U.S. GAAP. That framework does not by itself dictate how to value an entire physician or dental practice for every purpose, but it does matter when the assignment is for accounting rather than transaction advisory or tax. (IFRS Foundation, 2026; Financial Accounting Standards Board [FASB], 2011).
Tax allocation and goodwill
Tax allocation often changes the actual economics of a deal even when it does not change headline enterprise value. IRS Form 8594 and its instructions explain that both buyer and seller must report applicable asset acquisitions where a group of assets constitutes a trade or business and goodwill or going-concern value attaches or could attach. The instructions also emphasize that goodwill and going-concern value are key to determining when a group of assets is treated as a trade or business for Section 1060 reporting. For healthcare transactions, this is highly relevant because many practice sales are structured as asset sales or are treated as asset acquisitions for tax purposes. Purchase price allocation across equipment, covenants, software, records, goodwill, and other classes can materially affect after-tax proceeds to the seller and future deductions or amortization for the buyer. (IRS, 2021a, 2021b).
Practical transaction implications
For dental transactions, one recurring question is whether the observed purchase price reflects an individual buyer financing a practice based on transferable cash flow or a DSO paying for a system-compatible tuck-in. For medical transactions, a similar question is whether the case is a physician-to-physician deal, a hospital alignment transaction, or an MSO/PE structure. Those distinctions matter because the same practice can generate at least three analytically different numbers: fair market value, strategic value, and the seller’s best available market-clearing price. A rigorous valuation does not confuse them. (IVSC, 2025; GAO, 2025; Singh et al., 2025; Nasseh et al., 2020).
Open questions and limitations
A few limitations should be stated plainly. Small-practice transaction data remain relatively opaque, many of the best market multiple databases are proprietary, and public deal disclosures often do not provide enough detail to isolate whether the observed pricing reflects transferable standalone economics or buyer-specific synergies. State corporate-practice and fee-splitting rules can also materially affect deal structure, especially in medical transactions, and those issues vary too much by jurisdiction to be resolved in a national overview. For those reasons, the most defensible healthcare valuations usually triangulate income, market, and asset evidence rather than relying on any single benchmark or informal rule of thumb. (IRS, 2014; IVSC, 2025; GAO, 2025).
Practical Preparation and FAQ
Business owners usually improve both valuation quality and eventual transaction outcomes when they prepare the practice before asking for a number. The most useful preparation steps are not cosmetic. They are analytical and documentary: clean financial statements, clear provider-level production data, identified add-backs, realistic replacement compensation assumptions, current payer summaries, current equipment lists, lease documentation, working-capital detail, compliance records, and management plans for key-staff retention. Current ADA and AMA evidence makes the importance of this preparation obvious, because reimbursement pressure, staffing difficulty, and operating cost inflation are now central parts of the value conversation in both sectors. (ADA HPI, 2025; ADA HPI, 2026a; AMA, 2026a; MedPAC, 2026).
A practical seller checklist usually includes the following:
- Separate discretionary and personal spending from true operating expenses.
- Document owner-clinician duties so replacement compensation can be estimated credibly.
- Prepare three to five years of financial statements and tax returns.
- Summarize payer mix, reimbursement changes, denials, and network participation.
- Produce provider-level production, collection, and scheduling reports.
- Inventory equipment by age, condition, ownership status, and replacement needs.
- Confirm lease renewal options, assignment terms, and related-party real estate issues.
- Document staff tenure, compensation, and retention risk.
- Summarize compliance, privacy, credentialing, and billing controls.
- Explain near-term strategic changes such as associate hires, retirements, de novos, or service-line additions.
Those steps do not create value by themselves, but they reduce uncertainty, improve normalization, and allow stronger weighting on income and market evidence. (ASA, 2022; IVSC, 2025; HHS OCR, 2013).
Frequently asked questions
What is the best valuation method for a dental or medical practice?
There is no universal “best” method. For a healthy going-concern practice, the income approach is often the anchor because it captures the present value of maintainable earnings. The market approach is usually an important cross-check when reliable comparable transactions exist, while the asset approach becomes more important for start-ups, distressed practices, or entities with weak transferable goodwill. Standards from ASA and IVSC support using the approach or combination of approaches that best fits the facts and data quality. (ASA, 2022; IVSC, 2025).
Is EBITDA enough to value a practice?
No. EBITDA can be useful, especially in larger transactions, but it is not enough on its own. In healthcare, reported EBITDA often includes distortions from owner compensation, discretionary expenses, related-party rent, and unusual billing or staffing conditions. A credible valuation usually begins with adjusted EBITDA or another measure of maintainable earnings after fair replacement compensation and other normalization adjustments. (ASA, 2022; IVSC, 2025).
How do you separate personal goodwill from enterprise goodwill?
The core test is transferability. If cash flow depends primarily on the individual dentist’s or physician’s personal reputation, relationships, or clinical pull, that portion may be personal goodwill rather than enterprise goodwill. If cash flow is supported by systems, staff, location, contracts, multi-provider continuity, and patient loyalty to the practice itself, that portion is more likely enterprise goodwill. IRS guidance on closely held business valuation explicitly recognizes the effect of a “one-man” business and management succession risk. (IRS, 2014; AICPA & CIMA, 2022).
Why does payer mix change value so much?
Because payer mix affects both margin and risk. Low-rate or denial-prone payer exposure suppresses cash conversion, while concentrated dependence on a few plans increases vulnerability to contract changes. ADA’s current data show that reimbursement pressure is the top challenge for many dentists and that reimbursement has lagged inflation and practice costs. In medicine, CMS and MedPAC data show how strongly practice economics are tied to fee-schedule design and to the spread between Medicare and private reimbursement. (ADA HPI, 2025; ADA HPI, 2026a; CMS, 2026b; MedPAC, 2026).
Do private equity or hospital offers represent fair market value?
Not necessarily. They may represent the highest available bid, but that does not automatically mean standalone fair market value. IVS distinguishes market value from investment value and synergistic value, and public research shows that hospital or PE affiliation can be associated with higher negotiated prices. If the buyer expects synergies, rate improvements, or scale efficiencies unavailable to ordinary market participants, its offer may exceed fair market value. (IVSC, 2025; Singh et al., 2025; GAO, 2025).
When should the asset approach receive heavy weight?
Usually when the practice has weak or negative earnings, poor transferability of goodwill, large tangible asset value relative to profit, or a non-going-concern premise. Distressed specialty clinics, start-ups, and offices with severe provider dependency often require much more asset-approach emphasis than mature, profitable practices. ASA explicitly states that the asset approach is most relevant in certain enterprise-level cases and should not be the sole approach for operating going concerns unless well supported. (ASA, 2022).
How do pending retirements or associate departures affect value?
They usually affect value materially because they change the transferability and durability of cash flow. If the departing provider controls most production, referral relationships, or patient loyalty, the valuation may need a DCF with stepped-down revenue, increased recruitment cost, and a lower terminal value. The IRS discussion of “one-man” businesses is highly relevant here: lack of succession potential can depress value. (IRS, 2014; IVSC, 2025).
Can dropping insurance networks increase value?
Sometimes, but not automatically. Leaving low-rate networks can improve margin if patients stay and the practice has strong local demand. It can lower value if it causes patient attrition, weaker hygiene fill rates, or reputational damage. Current ADA data show many owners are actively reevaluating network participation, which means the impact should be modeled explicitly rather than guessed. (ADA HPI, 2025; ADA HPI, 2026a).
What records should an owner prepare before a valuation?
At minimum: three to five years of financial statements and tax returns, payroll detail, provider production reports, payer and fee schedule summaries, accounts receivable aging, equipment inventory, lease documents, debt schedules, working-capital detail, and any major compliance or litigation items. For dental practices, add active-patient and hygiene data. For medical practices, add provider compensation formulas, work RVUs or productivity data, and ancillary revenue support. IRS and ASA guidance both emphasize the importance of detailed historical and supporting schedules. (IRS, 2014; ASA, 2022).
Are patient records or EHR data part of the value?
Yes, but not in a simplistic sense. They support going-concern value and continuity of care, but their usefulness depends on lawful transfer, privacy compliance, and operational continuity. HHS guidance confirms that sale or transfer of assets can fall within healthcare operations under HIPAA, while also requiring minimum-necessary controls. In valuation terms, records support enterprise goodwill when they help sustain future earnings under lawful, workable transition planning. (HHS OCR, 2013, 2025).
How does the lease affect practice value?
More than many owners expect. A strong location with favorable rent and assignable lease rights supports value; a short lease with uncertain renewal, poor assignability, or above-market rent can materially reduce it. In healthcare, buyers are often buying the continuity of patient access in a specific site, not generic square footage. Related-party rent also needs normalization so the earnings base is not overstated or understated. (ASA, 2022; IRS, 2014).
How often should a practice get a valuation?
A full valuation is commonly warranted before a contemplated sale, partner admission, shareholder dispute, estate or gift planning event, significant compensation restructuring, or financing event. Outside those events, an annual or biennial update can be useful for management planning if the practice is growing, adding providers, changing payer strategy, or preparing for succession. The value of frequent updates is that they force the owner to track the drivers that truly matter—normalized earnings, transferability, concentration, and risk—rather than relying on stale rules of thumb. (IRS, 2014; IVSC, 2025).
References
AICPA & CIMA. (2022, April 10). Healthcare valuation.
American Dental Association Health Policy Institute. (2025). Economic outlook and emerging issues in dentistry: 4th quarter 2025.
American Dental Association Health Policy Institute. (2026a). State of the U.S. dental economy: Q4 2025.
American Medical Association. (2026a). Physician practice benchmark survey.
American Medical Association. (2026b). Physician Practice Benchmark Survey 2024: Physician compensation.
American Society of Appraisers. (2022). ASA business valuation standards.
Centers for Medicare & Medicaid Services. (2026a). Physician self-referral.
Centers for Medicare & Medicaid Services. (2026b). Physician fee schedule: CY 2026 final rule.
Financial Accounting Standards Board. (2011). Accounting Standards Update No. 2011-04, Fair value measurement (Topic 820): Amendments to achieve common fair value measurement and disclosure requirements in U.S. GAAP and IFRSs.
Government Accountability Office. (2025). Health care consolidation: Published estimates of the extent and effects of physician consolidation (GAO-25-107450).
Internal Revenue Service. (2014). Valuation of non-controlling interests in electing S corporations: A job aid for IRS valuation analysts.
Internal Revenue Service. (2021a). About Form 8594, Asset Acquisition Statement Under Section 1060.
Internal Revenue Service. (2021b). Instructions for Form 8594.
International Valuation Standards Council. (2025). International valuation standards.
IFRS Foundation. (2026). IFRS 13 Fair Value Measurement.
Medicare Payment Advisory Commission. (2025). Physician and other health professional payment system.
Medicare Payment Advisory Commission. (2026). Assessing payment adequacy and updating payments: Clinician services.
Nasseh, K., Bowblis, J. R., Vujicic, M., & Huang, S. S. (2020). Consolidation in the dental industry: A closer look at dental payers and providers. International Journal of Health Economics and Management, 20(2), 145–162.
Singh, Y., Radhakrishnan, N., Adler, L., & Whaley, C. (2025). Growth of private equity and hospital consolidation in primary care and price implications. JAMA Health Forum, 6(1), e244935.
U.S. Department of Health and Human Services, Office for Civil Rights. (2013). Uses and disclosures for treatment, payment, and health care operations.
U.S. Department of Health and Human Services, Office for Civil Rights. (2025). Summary of the HIPAA Privacy Rule.
U.S. Department of Health and Human Services, Office of Inspector General. (n.d.). Fraud & abuse laws.